| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| R&D Expense | $1.5M | — | -87.3% |
| SG&A Expense | $5.2M | — | -4.4% |
| Operating Income | -$7.4M | — | +58.2% |
| Income Tax | $0 | — | — |
| Net Income | -$5.8M | — | +65.2% |
| EPS (Basic) | -$0.78 | — | +65.6% |
| EPS (Diluted) | -$0.78 | — | +65.6% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $66.2M | -7.9% | +79.0% |
| Current Assets | $67.6M | -10.8% | -43.8% |
| Total Assets | $68.0M | -11.3% | -45.7% |
| Current Liabilities | $2.8M | -58.0% | -83.7% |
| Total Liabilities | $2.8M | -58.0% | -87.6% |
| Stockholders' Equity | $65.2M |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$7.4M | — | +56.7% |
| Capital Expenditures | $0 | — | -100.0% |
| Investing Cash Flow | $1.5M | — | -88.9% |
| Financing Cash Flow | $267K | — | +120.5% |
| Free Cash Flow | -$7.4M | — | +56.7% |
| -36.7% |